본문으로 건너뛰기
← 뒤로

Role of HOXA transcript antisense RNA myeloid-specific 1 in cancer (Review).

1/5 보강
Oncology letters 2026 Vol.31(2) p. 57
Retraction 확인
출처

Jing Y, Li X, Guo Y

📝 환자 설명용 한 줄

A newly recognized class of master regulators known as long non-coding RNAs (lncRNAs) has emerged as key modulators of cancer.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Jing Y, Li X, Guo Y (2026). Role of HOXA transcript antisense RNA myeloid-specific 1 in cancer (Review).. Oncology letters, 31(2), 57. https://doi.org/10.3892/ol.2025.15410
MLA Jing Y, et al.. "Role of HOXA transcript antisense RNA myeloid-specific 1 in cancer (Review).." Oncology letters, vol. 31, no. 2, 2026, pp. 57.
PMID 41383982

Abstract

A newly recognized class of master regulators known as long non-coding RNAs (lncRNAs) has emerged as key modulators of cancer. Among them, HOXA transcript antisense RNA myeloid-specific 1 (HOTAIRM1) was initially identified in acute promyelocytic leukemia, where it resides within the HOXA gene cluster. The involvement of HOTAIRM1 has been indicated in the pathogenesis of multiple cancer types, including glioma, acute myeloid leukemia and osteosarcoma, has been well documented. HOTAIRM1 controls the growth, invasion and migration of tumors through different mechanisms and it is associated with the clinicopathological characteristics of patients with tumors. The present review describes the expression, function and molecular mechanism of HOTAIRM1 in different types of cancer and discusses the future obstacles in diagnosing and treating malignant tumors.

같은 제1저자의 인용 많은 논문 (5)